Delivery Order SPE2DB20D2104-SPE2DB25FMYQU
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,346.88 to AmerisourceBergen Drug Corp for the supply of Entresto 97 mg-103 mg tablets (180-count) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order represents a non-competitive award under the company's broader indefinite delivery contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,962.22 on August 4, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count). This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $83,524.51 on July 22, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 23, 2025. AmerisourceBergen will perform the delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Entresto 97 mg-103 mg tablets (180-count units) under a firm fixed-price contract with a ceiling value of $5,359.73. This non-competitive delivery order is set to be completed by August 25, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of the company's role as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,188.82 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (60-count units) on July 25, 2025, with completion scheduled for July 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and represents a continuation of pharmaceutical procurement through DLA's existing contract vehicle. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $68,784.07 delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 49 mg-51 mg tablets (180-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a direct fulfillment under the company's broader pharmaceutical supply arrangements. The place of performance is AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $8,037.83 to AmerisourceBergen Drug Corp for the supply of Entresto 97 mg-103 mg tablets (180-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $38,756.30 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180 count) under a firm fixed price contract. The award was made on August 11, 2025, with an ultimate completion date of August 12, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location in the same jurisdiction. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count package) valued at $30,553.34 under a firm fixed-price delivery order with no set-aside designation. The contract is scheduled for ultimate completion on August 22, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a continuation of the company's...
- The Defense Logistics Agency awarded a $3,689.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Entresto 24 mg-26 mg tablets (60-count supply) on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-competitive delivery order was placed against AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled at...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMYQUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,325.99 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (60 count) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract is performed at the awardee's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major pharmaceutical distributor and healthcare solutions provider. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including support for the Defense Health Agency and other federal healthcare systems. The parent IDC reflects AmerisourceBergen's demonstrated capability to meet federal procurement requirements across multiple therapeutic domains and product categories through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 8/22/25 |